Concepedia

Xalud Therapeutics (United States)

XT

Statistics

Publications

35

Citations

25.1K

Authors

12

Location

San Francisco, United States

Xalud Therapeutics (United States) is a company institution in San Francisco, United States known for medicine, signal transduction, and immunology.

HomepageROR

Top concepts

Publications

35

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

Mitsuhiro Watanabe, Sander M. Houten, Li Wang et al. · Journal of Clinical Investigation · 2004 · 1.3K citations · Full text

Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle

Vamsi K. Mootha, Christoph Handschin, Dan Arlow et al. · Proceedings of the National Academy of Sciences · 2004 · 672 citations · Full text

, , +20

Redundant Pathways for Negative Feedback Regulation of Bile Acid Production

Li Wang, Yoon‐Kwang Lee, Donnie S. Bundman et al. · Developmental Cell · 2002 · 474 citations · Full text

, , +13

Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists

Eric D. Bischoff, Chris Daige, Diane Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 281 citations

Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression

Brandee Wagner, Annabel F. Valledor, Gang Shao et al. · Molecular and Cellular Biology · 2003 · 233 citations · Full text

, , +20

1–5 of 35

Authors

12

  1. PP
    P Pircher

    Xalud Therapeutics (United States), United States

    9 publications · 569 citations

    7

    h-index

  2. KG
    Kexiao Guo

    Xalud Therapeutics (United States), United States

    42 publications · 39 citations

    3

    h-index

  3. DT
    Diane Thomas

    Xalud Therapeutics (United States), United States

    8 publications · 717 citations

    2

    h-index

  4. KR
    Kathryn R. Penzkover

    Xalud Therapeutics (United States), United States

    2 publications · 153 citations

    2

    h-index

  5. GM
    Griffin Macondray

    Xalud Therapeutics (United States), United States

    2 publications · 135 citations

    2

    h-index

1–5 of 12